Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
-
-
-
Manufacturing ServicesNovo Refiles $16.5 Bn Catalent Acquisition to Extend FTC Review Period
4 min read • 2 years ago -
Discovery & DevelopmentRezdiffra Launches as First MASH Treatment with Promising Rapid Uptakes
4 min read • 2 years ago -
Regulatory & ComplianceStudy Reveals Many Fast-Tracked Cancer Drugs Fail to Show Long-Term Benefits
4 min read • 2 years ago -
Drug Delivery & PackagingOvercoming Brand Loyalty: Survey Suggests a Challenge for Generic Drugs
4 min read • 2 years ago -
Regulatory & ComplianceFDA Approves First BCMA-Targeted Relapsed or Refractory Multiple Myeloma Therapy
4 min read • 2 years ago -
-
-
Funding & InvestmentsAmylyx Withdraws ALS Drug Relyvrio Following Trial Failure; Cuts 70% of Staff
4 min read • 2 years ago -
Regulatory & ComplianceFDA Approves Zevtera for Multiple Bacterial Infections
4 min read • 2 years ago







